|
Post by peppy on May 7, 2019 7:26:40 GMT -5
|
|
|
Post by awesomo on May 7, 2019 7:39:32 GMT -5
|
|
|
Post by awesomo on May 7, 2019 7:46:44 GMT -5
Currently down 9% premarket.
|
|
|
Post by guidepost on May 7, 2019 7:55:30 GMT -5
Currently down 9% premarket. Have a buy order at 1.40, we'll see...
|
|
|
Post by mnkdfann on May 7, 2019 7:56:59 GMT -5
At least they're not surprising us with this news within moments after the earnings call ends. IIRC, that situation happened a couple of years back.
|
|
|
Post by seanismorris on May 7, 2019 8:00:33 GMT -5
Currently down 9% premarket. MannKind is never up on investor calls... The best we could have hoped for is neutral, but with the marketing flop that wasn’t going to happen. We’ve blamed Afrezza sales on many things, but apparently docs don’t see the medical need... I’m looking at MannKinds pipeline for hope...
|
|
|
Post by awesomo on May 7, 2019 8:02:31 GMT -5
Currently down 9% premarket. MannKind is never up on investor calls... The best we could have hoped for is neutral, but with the marketing flop that wasn’t going to happen. We’ve blamed Afrezza sales on many things, but apparently docs don’t see the medical need... I’m looking at MannKinds pipeline for hope... Usually no, but we went up a good amount after the last earnings call.
|
|
|
Post by ilovekauai on May 7, 2019 8:03:55 GMT -5
Where is the shoutbox?
|
|
|
Post by seanismorris on May 7, 2019 8:09:40 GMT -5
MannKind is never up on investor calls... The best we could have hoped for is neutral, but with the marketing flop that wasn’t going to happen. We’ve blamed Afrezza sales on many things, but apparently docs don’t see the medical need... I’m looking at MannKinds pipeline for hope... Usually no, but we went up a good amount after the last earnings call. We went up so much are stock price went through the roof? When you spend more on getting a new customer than that customer brings in... you’re facing BIG problems. The Afrezza strategy isn’t working.
|
|
|
Post by morfu on May 7, 2019 8:15:59 GMT -5
So 9 dot something Mil$ on that stupid commercial this quarter.. so abut a quarter of the most recent dilution paid for that.. hmmpf
|
|
|
Post by novafett on May 7, 2019 8:22:19 GMT -5
Shout box?
|
|
|
Post by seanismorris on May 7, 2019 8:22:31 GMT -5
We’re getting a lot of mentions on United Therapeutics... that’s been a savior for MannKind. If we’re going to avoid any further dilution is going to come from partnerships...
Un-named compound for United Therapeutics?
|
|
|
Post by #NoMoreNeedles on May 7, 2019 8:26:48 GMT -5
Fully funded until 2020 I thought!?
|
|
|
Post by novafett on May 7, 2019 8:27:46 GMT -5
I feel like the only major improvement was the $12M milestone payment. That's not going to happen every quarter and won't mask bigger losses next go round
|
|
|
Post by mnkdfann on May 7, 2019 8:28:26 GMT -5
Fully funded until 2020 I thought!? You have to consider the source (of such news).
|
|